keyword
https://read.qxmd.com/read/35700913/contribution-of-socio-economic-factors-in-the-spread-of-antimicrobial-resistant-infections-in-australian-primary-healthcare-clinics
#21
JOURNAL ARTICLE
Teresa M Wozniak, Will Cuningham, Katie Ledingham, Karen McCulloch
OBJECTIVES: To effectively contain antimicrobial-resistant (AMR) infections, we must better understand the social determinates of health that contribute to transmission and spread of infections. METHODS: We used clinical data from patients attending primary healthcare clinics across three jurisdictions of Australia (2007-2019). Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumoniae), Pseudomonas aeruginosa (P. aeruginosa) and Staphylococcus aureus (S. aureus) isolates and their corresponding antibiotic susceptibilities were included...
June 11, 2022: Journal of Global Antimicrobial Resistance
https://read.qxmd.com/read/35656828/omadacycline-and-clostridioides-difficile-a-systematic-review-of-preclinical-and-clinical-evidence
#22
JOURNAL ARTICLE
Kevin W Garey, Warren Rose, Kyle Gunter, Alisa W Serio, Mark H Wilcox
OBJECTIVE: The objective of this systematic review is to summarize in vitro, preclinical, and human data related to omadacycline and Clostridioides difficile infection (CDI). DATA SOURCES: PubMed and Google Scholar were searched for "omadacycline" AND (" Clostridium difficile " OR " C difficile " OR " Clostridioides difficile ") for any studies published before February 15, 2022. The US Food and Drug Administration (FDA) Adverse Events Reporting System (AERS) was searched for omadacycline (for reports including " C...
June 3, 2022: Annals of Pharmacotherapy
https://read.qxmd.com/read/35641073/bioelectric-effect-utilized-a-healthcare-device-for-effective-management-of-dental-biofilms-and-gingivitis
#23
JOURNAL ARTICLE
Young Wook Kim, Jihyun Lee, Tae-Hoon Lee, Seungmo Lim
Oral healthcare is a critical condition for high quality of life. According to statistics, gingivitis is one of major diseases in the world (The Global Burden of Disease Study 2019, 3.5 billion population worldwide). Oral diseases, that initiated by a group of multispecies bacteria with diverse extracellular slime that called biofilms, are modifiable risk factors with the cancer, cardiovascular disease, chronic respiratory disease. Hence, effective management of biofilms is important. Since biofilms are comprised of extracellular matrix that inhibit drug diffusion, the traditional antibiotic treatment requires 500 -5000 times more concentration than planktonic bacterial infection...
June 2022: Medical Engineering & Physics
https://read.qxmd.com/read/35625192/what-doesn-t-kill-them-makes-them-stronger-the-impact-of-the-resistance-patterns-of-urinary-enterobacterales-isolates-in-patients-from-a-tertiary-hospital-in-eastern-europe
#24
JOURNAL ARTICLE
Ionela-Larisa Miftode, Maria-Antoanela Pasare, Radu-Stefan Miftode, Eduard Nastase, Claudia Elena Plesca, Catalina Lunca, Egidia-Gabriela Miftode, Amalia-Stefana Timpau, Luminita Smaranda Iancu, Olivia Simona Dorneanu
(1) Background: The evolution of bacterial resistance to antibiotics is one of the factors that make infectious pathology an extremely dynamic field, also inducing a significant burden on public health systems; therefore, continuous updates on the bacterial resistance to antibiotics and their particular regional patterns is crucial for the adequate approach of various infectious diseases. (2) Methods: We retrospectively analyzed 354 patients with Enterobacterales urinary tract infections (UTIs), determined their antibiotic resistance pattern, thus aiming to correlate them with the outcome and other specific markers of poor prognosis...
April 20, 2022: Antibiotics
https://read.qxmd.com/read/35560774/genesis-of-antibiotic-resistance-ar-lxxviii-turbulence-modeling-of-hemodynamics-in-simplified-severe-sepsis-protocol-2-sssp-2-nct01663701-erp-egdt-correlation-of-time-fluid-bolus-dependent-pressure-drop-in-boundary-layer-separation-with-adverse-pressure-gradient
#25
JOURNAL ARTICLE
Natalie Padilla, Dania Alvizo, Subburaj Kannan
The objective is to identify the underlying hemodynamic alteration in usual care group registered with 5 patients @ 100% ihm; vs the sepsis protocol cohort registered with 11 patients @ 90.05% ihmwith a median hospital stay of 5 days; GCS 3-8(SAPS3≥56, (Ref: Fig 3) NCT01663701(PMID: 28973227). Cause for Concern: The pivotal clinical indices such as, i. antibiogram, ii.drug resistance index(DRI), iii.resistance map(RM), iv.antibiotic resistance footprint (ARF), v.AR stewardship data, and vi. Global Antimicrobial Resistance and Use Surveillance System (GLASS) data, for the entire patients' cohorts before and after admitting to ED as a part of baseline characteristics, not presented...
May 2022: FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology
https://read.qxmd.com/read/35334546/experience-of-vancomycin-therapeutic-drug-monitoring-in-two-multidisciplinary-hospitals-in-latvia
#26
JOURNAL ARTICLE
Inga Mauliņa, Karīna Darbiniece, Lāsma Miķelsone-Jansone, Renārs Erts, Dace Bandere, Angelika Krūmiņa
Background and Objectives : Management of infectious diseases is a huge burden to every healthcare system worldwide. Antimicrobial resistance, including antibacterial resistance, is an increasing problem worldwide; therefore, more new antibiotics are necessary to be discovered. Meanwhile, "old" antibacterial agents are still administered to fight infectious diseases caused by resistant bacteria. One of these antibacterial agents is vancomycin, which is effective in treating serious systemic infections caused by gram-positive bacteria...
March 2, 2022: Medicina
https://read.qxmd.com/read/35322729/biological-investigation-of-n-methyl-thiosemicarbazones-as-antimicrobial-agents-and-bacterial-carbonic-anhydrases-inhibitors
#27
JOURNAL ARTICLE
Ilaria D'Agostino, Githa Elizabeth Mathew, Paola Angelini, Roberto Venanzoni, Giancarlo Angeles Flores, Andrea Angeli, Simone Carradori, Beatrice Marinacci, Luigi Menghini, Mohamed A Abdelgawad, Mohammed M Ghoneim, Bijo Mathew, Claudiu T Supuran
The enormous burden of the COVID-19 pandemic in economic and healthcare terms has cast a shadow on the serious threat of antimicrobial resistance, increasing the inappropriate use of antibiotics and shifting the focus of drug discovery programmes from antibacterial and antifungal fields. Thus, there is a pressing need for new antimicrobials involving innovative modes of action (MoAs) to avoid cross-resistance rise. Thiosemicarbazones (TSCs) stand out due to their easy preparation and polypharmacological application, also in infectious diseases...
December 2022: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/35071521/zinc-carnosine-based-modified-bismuth-quadruple-therapy-vs-standard-triple-therapy-for-helicobacter-pylori-eradication-a-randomized-controlled-study
#28
JOURNAL ARTICLE
Nour Ibrahim, Hassan El Said, Ali Choukair
BACKGROUND: Helicobacter pylori ( H. pylori ) infection is a worldwide problem with increasing burden on the health sector due to its increasing rate of resistance. The conventional triple therapy (TT) is becoming obsolete with a high failure rate of eradication, necessitating the need for better alternatives or regimens. AIM: To investigate H. pylori eradication rate of TT vs modified bismuth quadruple therapy. METHODS: Ninety-two patients with dyspepsia symptoms and positive 13 C-urea breath test were randomly assigned to two groups...
January 7, 2022: World Journal of Clinical Cases
https://read.qxmd.com/read/34988445/activity-of-temocillin-against-third-generation-cephalosporin-resistant-escherichia-coli-and-klebsiella-pneumoniae-bloodstream-isolates-from-a-clinical-trial
#29
JOURNAL ARTICLE
Adam G Stewart, Andrew Henderson, Michelle J Bauer, David L Paterson, Patrick N A Harris
Background: Extended spectrum β-lactamase (ESBL) and AmpC-producing Gram-negative bacilli contribute significantly to the antimicrobial resistance (AMR) burden worldwide. Temocillin is an intravenous semisynthetic antibiotic that is stable to hydrolysis by ESBLs and AmpC. Temocillin may be a treatment option for serious infections due to these organisms. Methods: Third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from the MERINO trial were collected...
March 2022: JAC-antimicrobial resistance
https://read.qxmd.com/read/34908453/repurposing-approved-drugs-as-fluoroquinolone-potentiators-to-overcome-efflux-pump-resistance-in-staphylococcus-aureus
#30
JOURNAL ARTICLE
Nisha Mahey, Rushikesh Tambat, Nishtha Chandal, Dipesh Kumar Verma, Krishan Gopal Thakur, Hemraj Nandanwar
Staphylococcus aureus is a versatile human commensal bacteria and pathogen that causes various community and hospital-acquired infections. The S. aureus efflux pump NorA which belongs to the major facilitator superfamily, confers resistance to a range of substrates. Many efflux pump inhibitors (EPIs) have been discovered, but none is clinically approved due to their undesirable toxicities. In this study, we have screened clinically approved drugs for possible NorA EPI-like activity. We identified six drugs that showed the best efflux pump inhibition in vitro , with a fractional inhibitory concentration index of ≤0...
December 15, 2021: Microbiology Spectrum
https://read.qxmd.com/read/34766544/layer-by-layer-coated-hybrid-nanoparticles-with-ph-sensitivity-for-drug-delivery-to-treat-acute-lung-infection
#31
JOURNAL ARTICLE
Ji Luo, Xiaobo Li, Siyuan Dong, Peiyao Zhu, Wenke Liu, Shuguang Zhang, Jiang Du
Bacteria-induced acute lung infection (ALI) is a severe burden to human health, which could cause acute respiratory distress syndrome (ARDS) and kill the patient rapidly. Therefore, it is of great significance to develop effective nanomedicine and therapeutic approach to eliminate the invading bacteria in the lung and manage ALI. In this study, we design a layer-by-layer (LbL) liposome-polymer hybrid nanoparticle (HNP) with a pH-triggered drug release profile to deliver antibiotics for the eradication of bacteria to treat ALI...
December 2021: Drug Delivery
https://read.qxmd.com/read/34663394/nmpa-approved-traditional-chinese-medicine-pingwei-pill-new-indication-for-colistin-recovery-against-mcr-positive-bacteria-infection
#32
JOURNAL ARTICLE
Qiushuang Sheng, Runbao Du, Cunhui Ma, Yonglin Zhou, Xue Shen, Xiaoning Hou, Lei Xu, Li Li, Xuming Deng, Jianfeng Wang
BACKGROUND: The wide spread of plasmid-mediated colistin resistance by mobile colistin resistance (MCR) in Enterobacteriaceae severely limits the clinical application of colistin as a last-line drug against bacterial infection. The identification of colistin potentiator from natural plants or their compound preparation as antibiotic adjuncts is a new promising strategy to meet this challenge. METHODS: Herein, the synergistic activity, as well as the potential mechanism, of Pingwei pill plus antibiotics against MCR-positive Gram-negative pathogens was examined using checkerboard assay, time-killing curves, combined disk test, western blot assay, and microscope analysis...
October 18, 2021: Chinese Medicine
https://read.qxmd.com/read/34543096/gepotidacin-pharmacokinetics-pharmacodynamics-against-escherichia-coli-in-the-one-compartment-and-hollow-fiber-in-vitro-infection-model-systems
#33
JOURNAL ARTICLE
Brian D VanScoy, Elizabeth A Lakota, Haley Conde, Steven Fikes, Sujata M Bhavnani, Philippa B Elefante, Nicole E Scangarella-Oman, Paul G Ambrose
Gepotidacin is a novel, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by a distinct mechanism of action with an in vitro spectrum of activity that includes Escherichia coli . Our objectives herein were the following: 1) to identify the pharmacokinetic-pharmacodynamics (PK-PD) index associated with efficacy for gepotidacin against E. coli ; 2) to determine the magnitude of the above-described PK-PD index associated with various bacterial reduction endpoints for E. coli ; and 3) to characterize the relationship between gepotidacin exposure and on-therapy E...
September 20, 2021: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/34510389/drug-related-problems-in-hospitalised-patients-with-chronic-kidney-disease-a-systematic-review
#34
Wadia S Alruqayb, Malcolm J Price, Vibhu Paudyal, Anthony R Cox
INTRODUCTION: Globally, chronic kidney disease (CKD) is one of the leading causes of mortality. Impaired renal function makes CKD patients vulnerable to drug-related problems (DRPs). AIM: The aim of this systematic review was to investigate the prevalence and nature of DRPs among hospital in-patients with CKD. METHODS: A systematic review of the literature was conducted using Medline, EMBASE, PsycINFO, Web of Science (Core Collection), CINAHL plus (EBSCO), Cochrane Library (Wiley), Scopus (ELSEVIER) and PubMed (U...
October 2021: Drug Safety: An International Journal of Medical Toxicology and Drug Experience
https://read.qxmd.com/read/34463660/does-operative-management-of-epidural-abscesses-increase-healthcare-expenditures-up-to-1-year-after-treatment
#35
JOURNAL ARTICLE
Grace X Xiong, Alexander M Crawford, Brian C Goh, Brendan M Striano, Gordon P Bensen, Andrew J Schoenfeld
BACKGROUND: The incidence of spinal epidural abscesses is increasing. What is more, they are associated with high rates of morbidity and mortality. Advances in diagnostic imaging and antibiotic therapies have made earlier diagnosis and nonoperative management feasible in appropriately selected patients. Nonoperative treatment also has the advantage of lower immediate healthcare charges; however, it is unknown whether initial nonoperative care leads to higher healthcare charges long term...
August 31, 2021: Clinical Orthopaedics and related Research
https://read.qxmd.com/read/34356771/prevalence-and-characterization-of-extended-spectrum-%C3%AE-lactamase-producing-antibiotic-resistant-escherichia-coli-and-klebsiella-pneumoniae-in-ready-to-eat-street-foods
#36
JOURNAL ARTICLE
Shobha Giri, Vaishnavi Kudva, Kalidas Shetty, Veena Shetty
As the global urban populations increase with rapid migration from rural areas, ready-to-eat (RTE) street foods are posing food safety challenges where street foods are prepared with less structured food safety guidelines in small and roadside outlets. The increased presence of extended-spectrum-β-lactamase (ESBL) producing bacteria in street foods is a significant risk for human health because of its epidemiological significance. Escherichia coli and Klebsiella pneumoniae have become important and dangerous foodborne pathogens globally for their relevance to antibiotic resistance...
July 13, 2021: Antibiotics
https://read.qxmd.com/read/34163361/cefdinir-and-%C3%AE-lactamase-inhibitor-independent-efficacy-against-mycobacterium-tuberculosis
#37
JOURNAL ARTICLE
Shashikant Srivastava, Tania Thomas, Dave Howe, Lesibana Malinga, Prithvi Raj, Jan-Willem Alffenaar, Tawanda Gumbo
Background: There is renewed interest in repurposing β-lactam antibiotics for treatment of tuberculosis (TB). We investigated efficacy of cefdinir, that withstand the β-lactamase enzyme present in many bacteria, against drug-susceptible and multi-drug resistant (MDR) Mycobacterium tuberculosis ( Mtb ). Methods: Minimum inhibitory concentration (MIC) experiments were performed with Mtb H37Ra, eight drug-susceptible, and 12 MDR-TB clinical isolates with and without the β-lactamase inhibitor, avibactam at 15 mg/L final concentration...
2021: Frontiers in Pharmacology
https://read.qxmd.com/read/33928790/design-synthesis-and-antibacterial-evaluation-of-ocotillol-derivatives-with-polycyclic-nitrogen-containing-groups
#38
JOURNAL ARTICLE
Yucheng Cao, Kaiyi Wang, Jiali Wang, Haoran Cheng, Mengxin Ma, Qingguo Meng, Xiaopeng Li, Yi Bi
Aim: With the increasing abuse of antibacterial drugs, multidrug-resistant bacteria have become a burden on human health and the healthcare system. To find alternative compounds effective against hospital-acquired methicillin-resistant Staphylococcus aureus  (HA-MRSA), novel derivatives of ocotillol were synthesized. Methods & Results: Ocotillol derivatives with polycyclic nitrogen-containing groups were synthesized and evaluated for in vitro antibacterial activity. Compounds 36-39 exhibited potent antibacterial activity against hospital-acquired MRSA, with MIC = 8-64 μg/ml...
April 30, 2021: Future Medicinal Chemistry
https://read.qxmd.com/read/33848538/current-prescribing-practices-and-guideline-concordance-for-the-treatment-of-uncomplicated-urinary-tract-infections-in-women
#39
JOURNAL ARTICLE
Joanna L Langner, Kim F Chiang, Randall S Stafford
BACKGROUND: Uncomplicated urinary tract infections are one of the most common bacterial infections in the United States. Clinical practice guidelines from the Infectious Diseases Society of America recommend nitrofurantoin, trimethoprim-sulfamethoxazole, and Fosfomycin as first-line antibiotic treatments and discourage the use of fluoroquinolone antibiotic agents. US Food and Drug Administration released several black box warnings about fluoroquinolones over the past decade owing to antibiotic resistance and a high burden of adverse events...
September 2021: American Journal of Obstetrics and Gynecology
https://read.qxmd.com/read/33492485/pharmacological-evaluation-of-prophylactic-anti-microbial-use-in-laparoscopic-cholecystectomy-an-open-labelled-study-evaluating-the-concentrations-of-single-dose-intravenous-ceftriaxone-at-serum-and-tissue-level
#40
JOURNAL ARTICLE
Sheikh Salim, Malik Neeraj Kumar, Chakar Dhar Tripathi, Satya V Arya, Veena Verma, Karim Bushra Ahmed, Girish Gulab Meshram
OBJECTIVE: The goal of administering preoperative systemic prophylactic antibiotics is to have the concentration in the tissues at its optimum level at the start and throughout the surgery. The rationale for the use of antibiotics is not well accepted; possible side effects and development of microbial resistance patterns are potential risks along with the financial burden. Therefore, the present study was conducted with the aim to clinically evaluate the serum and tissue concentration of single-dose prophylactic ceftriaxone during an ongoing laparoscopic cholecystectomy (LC) and to find out risk factors for post operative surgical site infections (SSI)...
July 2021: European Journal of Clinical Pharmacology
keyword
keyword
170861
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.